Jazz Pharmaceuticals JAZZ Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's other noncash income (expense)?
- Jazz Pharmaceuticals (JAZZ) reported other noncash income (expense) of -$3.9M in Q1 2026.
- How has Jazz Pharmaceuticals's other noncash income (expense) changed year-over-year?
- Jazz Pharmaceuticals's other noncash income (expense) decreased by 160.0% year-over-year, from $6.5M to -$3.9M.